Sickle cell disease: Loss of the blood's WD40?

Trends in Pharmacological Sciences

Volumn 24, Issue 8, 2003, Pages 389-391

  Lancaster Jr , Jack R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARBON MONOXIDE; HEMOGLOBIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADHESION; ANTICOAGULATION; BLOOD; BLOOD CLOTTING; BLOOD FLOW; DRUG EFFECT; HUMAN; INFLAMMATION; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; UPREGULATION; VASODILATATION;

EID: 0043162109     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00199-8     Document Type: Short Survey

References (24)

1. Vichinsky E. New therapies in sickle cell disease. Lancet. 360:2002;629-631.
2. Reiter C.D., et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8:2002;1383-1389.
3. Ignarro L.J., et al. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ. Res. 61:1987;866-879.
4. Eich R.F., et al. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 35:1996;6976-6983.
5. Lancaster J.R. Jr. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 91:1994;8137-8141.
6. Carlsen E., Comroe J.H. The rate of uptake of carbon monoxide and of nitric oxide by normal human erythrocytes and experimentally produced spherocytes. J. Gen. Physiol. 42:1958;83-107.
7. Hartridge H., Roughton F.J.W. The rate of distribution of dissolved gases between the red blood corpuscle and its fluid environment. J. Physiol. 62:1927;232-242.
8. Liu X., et al. Diffusion-limited reaction of free nitric oxide with erythrocytes. J. Biol. Chem. 273:1998;18709-18713.
9. Liao J.C., et al. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8757-8761.
10. Pawloski J.R., Stamler J.S. Nitric oxide in RBCs. Transfusion. 42:2002;1603-1609.
11. Hobbs A.J., et al. Haemoglobin: NO transporter, NO inactivator or NOne of the above? Trends Pharmacol. Sci. 23:2002;406-411.
12. Gladwin M.T., et al. Nitric oxide reactions with hemoglobin: a view through the sno-storm. Nat. Med. 9:2003;496-500.
13. Stuart M.J., Setty B.N. Acute chest syndrome of sickle cell disease: new light on an old problem. Curr. Opin. Hematol. 8:2001;111-122.
14. Lopez B.L., et al. Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis. Am. J. Hematol. 64:2000;15-19.
15. Morris C.R., et al. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J. Pediatr. Hematol. Oncol. 22:2000;515-520.
16. Rees D.C., et al. The metabolites of nitric oxide in sickle-cell disease. Br. J. Haematol. 91:1995;834-837.
17. Girgis R.E., et al. Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement. Am. J. Hematol. 72:2003;177-184.
18. Belhassen L., et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood. 97:2001;1584-1589.
19. Aslan M., et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;15215-15220.
20. Lopez B.L., et al. L-Arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department. Br. J. Haematol. 120:2003;532-534.
21. Morris C.R., et al. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am. J. Respir. Crit. Care Med. 168:2003;63-69.
22. Atz A.M., Wessel D.L. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology. 87:1997;988-990.
23. Sullivan K.J., et al. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit. Care Med. 27:1999;2563-2568.
24. Weiner D.L., et al. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. J. Am. Med. Assoc. 289:2003;1136-1142.